SCHEMBL11301394

SCHEMBL11301394

COC(=O)c1ccc(N(c2ccc3[nH]c(=O)ccc3c2)C2CCNC2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A2 P23975 8/20 0.40
▸ SLC6A4 P31645 8/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ PDE5A O76074 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ PTAFR P25105 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ BLM P54132 1/20 0.39
▸ PDE1A P54750 1/20 0.39
▸ PDE1B Q01064 1/20 0.39
▸ PMP22 Q01453 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ PDE3B Q13370 1/20 0.39
▸ PDE1C Q14123 1/20 0.39
▸ PDE3A Q14432 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11296509 0.80 KDR (0.43) SLC6A2SLC6A4KDM4EALDH1A1HPGD
SCHEMBL11299962 0.80 SLC6A4 (0.39) SLC6A2SLC6A4KDM4EMEN1KMT2A
SCHEMBL11294920 0.74 KDR (0.39) SLC6A2SLC6A4SLC6A3TP53KDR
SCHEMBL11299107 0.74 HTT (0.40) SLC6A2SLC6A4KDM4EMEN1ALDH1A1
SCHEMBL30159581 0.74 CREBBP (0.54) KDM4EMEN1ALDH1A1HPGDTSHR
SCHEMBL16881173 0.74 CREBBP (0.54) KDM4EMEN1ALDH1A1HPGDTSHR
SCHEMBL28363673 0.73 NOTUM (0.43) SLC6A2SLC6A4KDM4EMEN1ALDH1A1
SCHEMBL15046545 0.70 KIF11 (0.53) KDM4EMEN1ALDH1A1HPGDTSHR
SCHEMBL18361035 0.68 NOTUM (0.46) KDM4EMEN1ALDH1A1HPGDTSHR
SCHEMBL11304997 0.67 HDAC6 (0.33) SLC6A2SLC6A4KDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback